Qinfen Xie

462 total citations
25 papers, 307 citations indexed

About

Qinfen Xie is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Qinfen Xie has authored 25 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Qinfen Xie's work include Organ Transplantation Techniques and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Qinfen Xie is often cited by papers focused on Organ Transplantation Techniques and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Qinfen Xie collaborates with scholars based in China, United States and Austria. Qinfen Xie's co-authors include Shusen Zheng, Haiyang Xie, Lin Zhou, Lanjuan Li, Xiao Xu, Yufu Ye, Feng Gao, Junhao Cheng, Chunyang Xing and Xiaowen Feng and has published in prestigious journals such as Journal of Clinical Oncology, Transplantation and Medicine.

In The Last Decade

Qinfen Xie

22 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinfen Xie China 13 120 99 87 80 76 25 307
José Luis Montero-Álvarez Spain 8 178 1.5× 145 1.5× 82 0.9× 93 1.2× 44 0.6× 12 343
Ting‐Jung Wu Taiwan 11 165 1.4× 113 1.1× 82 0.9× 112 1.4× 64 0.8× 21 359
Hiroaki Nagano Japan 11 188 1.6× 133 1.3× 56 0.6× 114 1.4× 33 0.4× 41 374
Meng Yu China 6 147 1.2× 55 0.6× 65 0.7× 87 1.1× 24 0.3× 18 348
Nobuo Waguri Japan 10 140 1.2× 87 0.9× 82 0.9× 106 1.3× 53 0.7× 42 331
Yugo Kai Japan 11 81 0.7× 54 0.5× 64 0.7× 112 1.4× 55 0.7× 47 297
Maria Francesca Secchi Italy 7 127 1.1× 58 0.6× 127 1.5× 108 1.4× 28 0.4× 8 340
Akinari Morinaga Japan 10 79 0.7× 68 0.7× 87 1.0× 43 0.5× 123 1.6× 25 312
Ting Chang United States 9 170 1.4× 209 2.1× 137 1.6× 168 2.1× 121 1.6× 24 612
Chan Xie China 11 136 1.1× 55 0.6× 124 1.4× 151 1.9× 78 1.0× 32 400

Countries citing papers authored by Qinfen Xie

Since Specialization
Citations

This map shows the geographic impact of Qinfen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinfen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinfen Xie more than expected).

Fields of papers citing papers by Qinfen Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinfen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinfen Xie. The network helps show where Qinfen Xie may publish in the future.

Co-authorship network of co-authors of Qinfen Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Qinfen Xie. A scholar is included among the top collaborators of Qinfen Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinfen Xie. Qinfen Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yuyi, Di Wu, Qinfen Xie, et al.. (2025). Histone lactylation-boosted AURKB facilitates colorectal cancer progression by inhibiting HNRNPM-mediated PSAT1 mRNA degradation. Journal of Experimental & Clinical Cancer Research. 44(1). 233–233.
3.
Xie, Qinfen, et al.. (2024). Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma. Scandinavian Journal of Gastroenterology. 59(6). 730–736. 7 indexed citations
4.
Shao, Guoliang, Wentao Jiang, Huiling Xiang, et al.. (2024). The activity and safety of icaritin for patients with unresectable HCC: A real world, retrospective study.. Journal of Clinical Oncology. 42(16_suppl). e16181–e16181.
5.
Aguilera, Victoria, Claire Francoz, Gabriela Berlakovich, et al.. (2022). Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey. Transplant International. 35. 10506–10506. 5 indexed citations
6.
Feng, Shi, Qian Wang, Haitao Huang, et al.. (2021). Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. Journal of Cellular and Molecular Medicine. 25(3). 1750–1758. 15 indexed citations
7.
Wang, Kun, Di Lu, Yu-Hui Liu, et al.. (2021). Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study. HepatoBiliary Surgery and Nutrition. 10(1). 9–19. 14 indexed citations
8.
Yang, Zhe, Shuo Wang, Xinyao Tian, et al.. (2020). Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience. Hepatobiliary & pancreatic diseases international. 19(4). 365–370. 24 indexed citations
9.
Shu, Zheyue, et al.. (2020). Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells. Hepatobiliary & pancreatic diseases international. 19(6). 547–554. 6 indexed citations
10.
Yang, Zhe, et al.. (2020). Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma. Case Reports in Gastroenterology. 14(1). 98–102. 1 indexed citations
11.
Xie, Qinfen, Lidong Wang, & Shusen Zheng. (2020). Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose-Response. 18(2). 3794411849–3794411849. 12 indexed citations
12.
Yadav, Dipesh Kumar, Xueli Bai, Jianying Lou, et al.. (2019). ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice. 2019. 1–16. 21 indexed citations
13.
Xu, Xiao, Jun Chen, Qiang Wei, et al.. (2019). Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition). Hepatobiliary & pancreatic diseases international. 18(4). 307–312. 29 indexed citations
14.
Zheng, Shusen, et al.. (2018). Salvage liver transplant for hepatocellular carcinoma: rescues and benefits. Translational Gastroenterology and Hepatology. 3. 65–65. 12 indexed citations
15.
Chen, Ping, Qinfen Xie, Xuan Lü, et al.. (2017). Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA. Medicine. 96(33). e7766–e7766. 14 indexed citations
16.
Chen, Ping, Qinfen Xie, Ting Chen, et al.. (2017). Hepatitis B virus infection in hilly/mountainous regions of southeastern China: a locality-dependent epidemiology. BMC Infectious Diseases. 17(1). 809–809. 12 indexed citations
17.
Chen, Lin, Yufu Ye, Lin Zhou, et al.. (2011). Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice. Hepatobiliary & pancreatic diseases international. 10(2). 171–178. 16 indexed citations
18.
Ye, Yufu, Lin Zhou, Haiyang Xie, et al.. (2010). Th17 promotes acute rejection following liver transplantation in rats. Journal of Zhejiang University SCIENCE B. 11(11). 819–827. 38 indexed citations
19.
Cheng, Junhao, Lin Zhou, Qinfen Xie, et al.. (2010). The impact of miR‐34a on protein output in hepatocellular carcinoma HepG2 cells. PROTEOMICS. 10(8). 1557–1572. 57 indexed citations
20.
Cheng, Jun, Lin Zhou, Qinfen Xie, et al.. (2010). The impact of miR‐34a on protein output in hepatocellular carcinoma HepG2 cells. PROTEOMICS - CLINICAL APPLICATIONS. 4(8-9). 765–765. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Luis Montero-Álvarez Breakdown of academic impact, for papers by Ting‐Jung Wu Breakdown of academic impact, for papers by Hiroaki Nagano Breakdown of academic impact, for papers by Meng Yu Breakdown of academic impact, for papers by Nobuo Waguri Breakdown of academic impact, for papers by Yugo Kai Breakdown of academic impact, for papers by Maria Francesca Secchi Breakdown of academic impact, for papers by Akinari Morinaga Breakdown of academic impact, for papers by Ting Chang Breakdown of academic impact, for papers by Chan Xie
Rankless by CCL
2026